PHA / TRY

PHA / USDT

PHA / USDC

WAXP / USDT

FET / JPY

FET / USDT

FET / USDC

FET / TRY

FET / BNB

FET / BTC

币安人生 / TRY

DEGO / USDT

FORTH / USDT

A2Z / USDC

NTRN / USDT

A2Z / USDT

IDEX / USDT

IDEX / USDC

NTRN / TRY

HOOK / USDT

WEBSOL ENERGY SYSTEM LTD

BRAINBEES SOLUTIONS LTD

KIOCL LIMITED

INOX GREEN ENERGY SER LTD

RELIANCE INDUSTRIAL INFRA

DECCAN TRANSCON LEASING L

SHANTHALA FMCG PRODUCTS L

DEEP INDUSTRIES LIMITED

NIDAN LABS AND HEALTH LTD

VALIANT LABORATORIES LTD

METROPOLIS HEALTHCARE LTD

MAHA RASHTRA APEX COPR. L

HEALTHCARE GLOBAL LTD

AARADHYA DISPOSAL INDUS L

CRAYONS ADVERTISING LTD

READYMIX CONSTRU MACHI L

MICROPRO SOFTWARE SOL L

NOVA AGRITECH LIMITED

MARUSHIKA TECHNOLOGY LTD

SURANI STEEL TUBES LTD.

Click here to get full coverage on Agenus receives $20M payment under Zydus Life Sciences collaboration - MSN

Agenus receives $20M payment under Zydus Life Sciences collaboration  MSN

Agenus receives $20M payment under Zydus Life Sciences collaboration - MSN

Click here to get full coverage on AeroDel signs exclusive licensing arrangement with Zydus for launching Aerolife Mini™, India's First Foldable, 'Always Attached' pMDI Enhancer - Yahoo Finance Singapore

AeroDel signs exclusive licensing arrangement with Zydus for launching Aerolife Mini™, India's First Foldable, 'Always Attached' pMDI Enhancer  Yahoo Finance Singapore

AeroDel signs exclusive licensing arrangement with Zydus for launching Aerolife Mini™, India's First Foldable, 'Always Attached' pMDI Enhancer - Yahoo Finance Singapore

Click here to get full coverage on Agenus Triggers First $20M Contingent Payment Under Zydus Life Sciences Collaboration to Support BOT+BAL Manufacturing Needs - Business Wire

Agenus Triggers First $20M Contingent Payment Under Zydus Life Sciences Collaboration to Support BOT+BAL Manufacturing Needs  Business Wire

Agenus Triggers First $20M Contingent Payment Under Zydus Life Sciences Collaboration to Support BOT+BAL Manufacturing Needs - Business Wire

Click here to get full coverage on Lupin and Zydus Sign Licensing Agreement for Co-marketing Innovative Semaglutide Injection in India - lupin.com

Lupin and Zydus Sign Licensing Agreement for Co-marketing Innovative Semaglutide Injection in India  lupin.com

Lupin and Zydus Sign Licensing Agreement for Co-marketing Innovative Semaglutide Injection in India - lupin.com

Click here to get full coverage on Owning 75% in Zydus Lifesciences Limited (NSE:ZYDUSLIFE) means that insiders are heavily invested in the company's future - simplywall.st

Owning 75% in Zydus Lifesciences Limited (NSE:ZYDUSLIFE) means that insiders are heavily invested in the company's future  simplywall.st

Owning 75% in Zydus Lifesciences Limited (NSE:ZYDUSLIFE) means that insiders are heavily invested in the company's future - simplywall.st

Click here to get full coverage on India's Zydus Life agrees $120 million settlement with Astellas over bladder drug - Reuters

India's Zydus Life agrees $120 million settlement with Astellas over bladder drug  Reuters

India's Zydus Life agrees $120 million settlement with Astellas over bladder drug - Reuters

Click here to get full coverage on Agenus Triggers First $20 Million Contingent Payment Under Zydus Life Sciences Collaboration to Support BOT+BAL Manufacturing Needs - marketscreener.com

Agenus Triggers First $20 Million Contingent Payment Under Zydus Life Sciences Collaboration to Support BOT+BAL Manufacturing Needs  marketscreener.com

Agenus Triggers First $20 Million Contingent Payment Under Zydus Life Sciences Collaboration to Support BOT+BAL Manufacturing Needs - marketscreener.com

Click here to get full coverage on ZYDUSLIFE Outlook for the Week (March 16, 2026 – March 20, 2026) - Equitypandit

ZYDUSLIFE Outlook for the Week (March 16, 2026 – March 20, 2026)  Equitypandit

ZYDUSLIFE Outlook for the Week (March 16, 2026 – March 20, 2026) - Equitypandit

Click here to get full coverage on India's Zydus Life agrees $120 million settlement with Astellas over bladder drug - TradingView

India's Zydus Life agrees $120 million settlement with Astellas over bladder drug  TradingView

India's Zydus Life agrees $120 million settlement with Astellas over bladder drug - TradingView

Click here to get full coverage on Q3 Results On Feb 9: BSE, Zydus Life, Aurobindo Pharma, Amber — Check Estimates - NDTV Profit

Q3 Results On Feb 9: BSE, Zydus Life, Aurobindo Pharma, Amber — Check Estimates  NDTV Profit

Q3 Results On Feb 9: BSE, Zydus Life, Aurobindo Pharma, Amber — Check Estimates - NDTV Profit

Click here to get full coverage on Analysts Are Updating Their Zydus Lifesciences Limited (NSE:ZYDUSLIFE) Estimates After Its Second-Quarter Results - simplywall.st

Analysts Are Updating Their Zydus Lifesciences Limited (NSE:ZYDUSLIFE) Estimates After Its Second-Quarter Results  simplywall.st

Analysts Are Updating Their Zydus Lifesciences Limited (NSE:ZYDUSLIFE) Estimates After Its Second-Quarter Results - simplywall.st

Click here to get full coverage on Zydus Life shares: Systematix upgrades stock to 'buy', sees 18% upside; check target price - MSN

Zydus Life shares: Systematix upgrades stock to 'buy', sees 18% upside; check target price  MSN

Zydus Life shares: Systematix upgrades stock to 'buy', sees 18% upside; check target price - MSN

Click here to get full coverage on There Is A Reason Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) Price Is Undemanding - simplywall.st

There Is A Reason Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) Price Is Undemanding  simplywall.st

There Is A Reason Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) Price Is Undemanding - simplywall.st

Click here to get full coverage on Zydus Life among 3 stock trading ideas by Rajesh Palviya of Axis Securities - MSN

Zydus Life among 3 stock trading ideas by Rajesh Palviya of Axis Securities  MSN

Zydus Life among 3 stock trading ideas by Rajesh Palviya of Axis Securities - MSN

Click here to get full coverage on Zydus and RK Pharma enter into an exclusive licensing and commercialization agreement for a novel 505(b)(2) product of supportive oncology treatment for the USA market - Yahoo! Finance Canada

Zydus and RK Pharma enter into an exclusive licensing and commercialization agreement for a novel 505(b)(2) product of supportive oncology treatment for the USA market  Yahoo! Finance Canada

Zydus and RK Pharma enter into an exclusive licensing and commercialization agreement for a novel 505(b)(2) product of supportive oncology treatment for the USA market - Yahoo! Finance Canada

Click here to get full coverage on Here's Why Zydus Lifesciences (NSE:ZYDUSLIFE) Has Caught The Eye Of Investors - simplywall.st

Here's Why Zydus Lifesciences (NSE:ZYDUSLIFE) Has Caught The Eye Of Investors  simplywall.st

Here's Why Zydus Lifesciences (NSE:ZYDUSLIFE) Has Caught The Eye Of Investors - simplywall.st

Click here to get full coverage on Zydus Life shares snap 3-day slide on Zyrifa launch, Formycon partnership; stock up 2% - MSN

Zydus Life shares snap 3-day slide on Zyrifa launch, Formycon partnership; stock up 2%  MSN

Zydus Life shares snap 3-day slide on Zyrifa launch, Formycon partnership; stock up 2% - MSN

Click here to get full coverage on Is Zydus Lifesciences (NSE:ZYDUSLIFE) Using Too Much Debt? - simplywall.st

Is Zydus Lifesciences (NSE:ZYDUSLIFE) Using Too Much Debt?  simplywall.st

Is Zydus Lifesciences (NSE:ZYDUSLIFE) Using Too Much Debt? - simplywall.st

Click here to get full coverage on Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) Stock Been Rising: Are Strong Financials Guiding The Market? - simplywall.st

Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) Stock Been Rising: Are Strong Financials Guiding The Market?  simplywall.st

Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) Stock Been Rising: Are Strong Financials Guiding The Market? - simplywall.st

Click here to get full coverage on Zydus Life shares gain on partnership with Swiss biopharmaceutical company - Moneycontrol.com

Zydus Life shares gain on partnership with Swiss biopharmaceutical company  Moneycontrol.com

Zydus Life shares gain on partnership with Swiss biopharmaceutical company - Moneycontrol.com

Click here to get full coverage on Zydus Lifesciences Limited completes the acquisition of Agenus Inc.'s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S. - Yahoo Finance

Zydus Lifesciences Limited completes the acquisition of Agenus Inc.'s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S.  Yahoo Finance

Zydus Lifesciences Limited completes the acquisition of Agenus Inc.'s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S. - Yahoo Finance

Click here to get full coverage on Zydus Lifesciences Limited (NSE:ZYDUSLIFE) Looks Like A Good Stock, And It's Going Ex-Dividend Soon - simplywall.st

Zydus Lifesciences Limited (NSE:ZYDUSLIFE) Looks Like A Good Stock, And It's Going Ex-Dividend Soon  simplywall.st

Zydus Lifesciences Limited (NSE:ZYDUSLIFE) Looks Like A Good Stock, And It's Going Ex-Dividend Soon - simplywall.st

Click here to get full coverage on Zydus Lifesciences (NSE:ZYDUSLIFE) Is Increasing Its Dividend To ₹11.00 - simplywall.st

Zydus Lifesciences (NSE:ZYDUSLIFE) Is Increasing Its Dividend To ₹11.00  simplywall.st

Zydus Lifesciences (NSE:ZYDUSLIFE) Is Increasing Its Dividend To ₹11.00 - simplywall.st

Click here to get full coverage on Zydus Life may acquire US-firm Ardelyx, may raise funds via QIP to part-fund deal: Exclusive - CNBC TV18

Zydus Life may acquire US-firm Ardelyx, may raise funds via QIP to part-fund deal: Exclusive  CNBC TV18

Zydus Life may acquire US-firm Ardelyx, may raise funds via QIP to part-fund deal: Exclusive - CNBC TV18

Click here to get full coverage on Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) CEO Compensation Is Looking A Bit Stretched At The Moment - simplywall.st

Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) CEO Compensation Is Looking A Bit Stretched At The Moment  simplywall.st

Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) CEO Compensation Is Looking A Bit Stretched At The Moment - simplywall.st

Click here to get full coverage on Zydus Life Q2: Solid beat on bottom line, analysts mixed on growth outlook - Business Standard

Zydus Life Q2: Solid beat on bottom line, analysts mixed on growth outlook  Business Standard

Zydus Life Q2: Solid beat on bottom line, analysts mixed on growth outlook - Business Standard

Click here to get full coverage on Zydus and Formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab), in US and Canada - Yahoo! Finance Canada

Zydus and Formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab), in US and Canada  Yahoo! Finance Canada

Zydus and Formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab), in US and Canada - Yahoo! Finance Canada

Click here to get full coverage on Accumulate Zydus Lifesciences; target of Rs 1020: Prabhudas Lilladher - TradingView

Accumulate Zydus Lifesciences; target of Rs 1020: Prabhudas Lilladher  TradingView

Accumulate Zydus Lifesciences; target of Rs 1020: Prabhudas Lilladher - TradingView

Click here to get full coverage on Zydus Life may acquire US-firm Ardelyx; may fund deal via QIP - India Infoline

Zydus Life may acquire US-firm Ardelyx; may fund deal via QIP  India Infoline

Zydus Life may acquire US-firm Ardelyx; may fund deal via QIP - India Infoline

Click here to get full coverage on Stocks to Watch Today: Lupin, Angel One, Zydus Life, Shaily Engineering, KSB, Sanofi India, KP Energy,... - Moneycontrol.com

Stocks to Watch Today: Lupin, Angel One, Zydus Life, Shaily Engineering, KSB, Sanofi India, KP Energy,...  Moneycontrol.com

Stocks to Watch Today: Lupin, Angel One, Zydus Life, Shaily Engineering, KSB, Sanofi India, KP Energy,... - Moneycontrol.com

Click here to get full coverage on Zydus Lifesciences Gets Tax Demand Order Of 28 Million Rupees - TradingView

Zydus Lifesciences Gets Tax Demand Order Of 28 Million Rupees  TradingView

Zydus Lifesciences Gets Tax Demand Order Of 28 Million Rupees - TradingView

Click here to get full coverage on Buy, Sell Or Hold: L&T, TCS, Zydus Life, BSE, Godrej Properties, Jubilant FoodWorks — Ask Profit - MSN

Buy, Sell Or Hold: L&T, TCS, Zydus Life, BSE, Godrej Properties, Jubilant FoodWorks — Ask Profit  MSN

Buy, Sell Or Hold: L&T, TCS, Zydus Life, BSE, Godrej Properties, Jubilant FoodWorks — Ask Profit - MSN

Click here to get full coverage on Stocks to Watch Today: Biocon, Zydus Life, Indo Tech Transformers, Bharat Forge, Yasho Industries, RPP Infra Projects in focus on 05 September - TradingView

Stocks to Watch Today: Biocon, Zydus Life, Indo Tech Transformers, Bharat Forge, Yasho Industries, RPP Infra Projects in focus on 05 September  TradingView

Stocks to Watch Today: Biocon, Zydus Life, Indo Tech Transformers, Bharat Forge, Yasho Industries, RPP Infra Projects in focus on 05 September - TradingView

Click here to get full coverage on Ardelyx stock soars on report of potential Zydus Life acquisition - Investing.com

Ardelyx stock soars on report of potential Zydus Life acquisition  Investing.com

Ardelyx stock soars on report of potential Zydus Life acquisition - Investing.com

Click here to get full coverage on Zydus Life launches ANYRA for advanced eye care, shares react - CNBC TV18

Zydus Life launches ANYRA for advanced eye care, shares react  CNBC TV18

Zydus Life launches ANYRA for advanced eye care, shares react - CNBC TV18

Click here to get full coverage on Zydus Life Q3 result: Profit up marginally at ₹1,042 cr, revenue jumps 32% - Business Standard

Zydus Life Q3 result: Profit up marginally at ₹1,042 cr, revenue jumps 32%  Business Standard

Zydus Life Q3 result: Profit up marginally at ₹1,042 cr, revenue jumps 32% - Business Standard

Click here to get full coverage on Zydus Life beats Street in Q1, eyes biosimilars boost in US - Mint

Zydus Life beats Street in Q1, eyes biosimilars boost in US  Mint

Zydus Life beats Street in Q1, eyes biosimilars boost in US - Mint

Click here to get full coverage on Zydus Life cleared to sell life-saving cancer drug; SC tells Bristol Myers to map patents - The Economic Times

Zydus Life cleared to sell life-saving cancer drug; SC tells Bristol Myers to map patents  The Economic Times

Zydus Life cleared to sell life-saving cancer drug; SC tells Bristol Myers to map patents - The Economic Times

Click here to get full coverage on Stock Picks Today: BSE, Lenskart, Zydus Life, Navin Fluorine And More On Brokerage Radar - NDTV Profit

Stock Picks Today: BSE, Lenskart, Zydus Life, Navin Fluorine And More On Brokerage Radar  NDTV Profit

Stock Picks Today: BSE, Lenskart, Zydus Life, Navin Fluorine And More On Brokerage Radar - NDTV Profit

Click here to get full coverage on Zydus Lifesciences shares decline 3.13% amid volume surge - TradingView

Zydus Lifesciences shares decline 3.13% amid volume surge  TradingView

Zydus Lifesciences shares decline 3.13% amid volume surge - TradingView

Click here to get full coverage on Zydus Life's US arm announces FDA nod for paediatric drug CUTX-101 NDA resubmission - CNBC TV18 - LinkedIn

Zydus Life's US arm announces FDA nod for paediatric drug CUTX-101 NDA resubmission - CNBC TV18  LinkedIn

Zydus Life's US arm announces FDA nod for paediatric drug CUTX-101 NDA resubmission - CNBC TV18 - LinkedIn

Click here to get full coverage on Stocks to Watch for Feb 19: Zydus Life, TVS Motor, NCC, Jindal Saw and more - CNBC TV18 - LinkedIn

Stocks to Watch for Feb 19: Zydus Life, TVS Motor, NCC, Jindal Saw and more - CNBC TV18  LinkedIn

Stocks to Watch for Feb 19: Zydus Life, TVS Motor, NCC, Jindal Saw and more - CNBC TV18 - LinkedIn

Click here to get full coverage on Zydus Life receives USFDA nod for Cevimeline 30 mg capsules - Business Standard

Zydus Life receives USFDA nod for Cevimeline 30 mg capsules  Business Standard

Zydus Life receives USFDA nod for Cevimeline 30 mg capsules - Business Standard

Click here to get full coverage on Zydus Life shares jump up to 5% after Q3 revenue rises 30% to Rs 6,865 crore - Moneycontrol.com

Zydus Life shares jump up to 5% after Q3 revenue rises 30% to Rs 6,865 crore  Moneycontrol.com

Zydus Life shares jump up to 5% after Q3 revenue rises 30% to Rs 6,865 crore - Moneycontrol.com

Click here to get full coverage on Zydus Lifesciences net profit rises 2% as labour-code provision, taxes weigh on earnings - TradingView

Zydus Lifesciences net profit rises 2% as labour-code provision, taxes weigh on earnings  TradingView

Zydus Lifesciences net profit rises 2% as labour-code provision, taxes weigh on earnings - TradingView

Click here to get full coverage on Bajaj Auto, Zydus Life, Escorts Kubota: How to trade these 3 buzzing stocks - MSN

Bajaj Auto, Zydus Life, Escorts Kubota: How to trade these 3 buzzing stocks  MSN

Bajaj Auto, Zydus Life, Escorts Kubota: How to trade these 3 buzzing stocks - MSN

Click here to get full coverage on Zydus Life launches AI glucose monitors for real-time diabetes tracking - CNBC TV18

Zydus Life launches AI glucose monitors for real-time diabetes tracking  CNBC TV18

Zydus Life launches AI glucose monitors for real-time diabetes tracking - CNBC TV18

Click here to get full coverage on Zydus Life unit partners with Formycon to supply immunotherapy drug Keytruda biosimilar in US, Canada - CNBC TV18

Zydus Life unit partners with Formycon to supply immunotherapy drug Keytruda biosimilar in US, Canada  CNBC TV18

Zydus Life unit partners with Formycon to supply immunotherapy drug Keytruda biosimilar in US, Canada - CNBC TV18

Click here to get full coverage on Top stocks in news: RIL, AEL, Tata Motors, RVNL, Sun Pharma, LTTS, Zydus Life, GMDC, Nocil - Business Today

Top stocks in news: RIL, AEL, Tata Motors, RVNL, Sun Pharma, LTTS, Zydus Life, GMDC, Nocil  Business Today

Top stocks in news: RIL, AEL, Tata Motors, RVNL, Sun Pharma, LTTS, Zydus Life, GMDC, Nocil - Business Today

Click here to get full coverage on Zydus Life gets FDA nod for children’s lung treatment drug bosentan - CNBC TV18

Zydus Life gets FDA nod for children’s lung treatment drug bosentan  CNBC TV18

Zydus Life gets FDA nod for children’s lung treatment drug bosentan - CNBC TV18

Click here to get full coverage on Zydus Life shares: Systematix upgrades stock to 'Buy', sees 18% upside; check target price - Business Today

Zydus Life shares: Systematix upgrades stock to 'Buy', sees 18% upside; check target price  Business Today

Zydus Life shares: Systematix upgrades stock to 'Buy', sees 18% upside; check target price - Business Today

Click here to get full coverage on Hold Zydus Lifesciences: target of Rs 900 : ICICI Securities - TradingView

Hold Zydus Lifesciences: target of Rs 900 : ICICI Securities  TradingView

Hold Zydus Lifesciences: target of Rs 900 : ICICI Securities - TradingView

Click here to get full coverage on Zydus Life's US arm announces FDA nod for paediatric drug CUTX-101 NDA resubmission - CNBC TV18

Zydus Life's US arm announces FDA nod for paediatric drug CUTX-101 NDA resubmission  CNBC TV18

Zydus Life's US arm announces FDA nod for paediatric drug CUTX-101 NDA resubmission - CNBC TV18

Click here to get full coverage on Q3 results on Feb 9: BSE, Zydus Life, Aurobindo Pharma, Amber — check estimates - MSN

Q3 results on Feb 9: BSE, Zydus Life, Aurobindo Pharma, Amber — check estimates  MSN

ZYDUSLIFE

Price Chart

Key Statistics

Technicals

About ZYDUSLIFE

Latest News

Agenus receives $20M payment under Zydus Life Sciences collaboration - MSN

AeroDel signs exclusive licensing arrangement with Zydus for launching Aerolife Mini™, India's First Foldable, 'Always Attached' pMDI Enhancer - Yahoo Finance Singapore

Agenus Triggers First $20M Contingent Payment Under Zydus Life Sciences Collaboration to Support BOT+BAL Manufacturing Needs - Business Wire

Advanced Charts

Top Gainers

Top Losers